solo per uso di ricerca
N. Cat.: F3778
| Diluizione |
|---|
|
| Applicazione |
|---|
| WB, IP, IHC, FCM |
| Reattività |
|---|
| Mouse, Rat, Human |
| Fonte |
|---|
| Rabbit Monoclonal Antibody |
| Tampone di conservazione |
|---|
| PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3 |
| Conservazione (dalla data di ricezione) |
|---|
| -20°C (avoid freeze-thaw cycles), 2 years |
| PM previsto PM osservato |
|---|
| 97 kDa 120 kDa |
| *Perché i pesi molecolari previsti e reali differiscono? Le seguenti ragioni possono spiegare le differenze tra il peso molecolare della proteina previsto e quello reale. |
| Controllo positivo | Human colon carcinoma; Human ovarian carcinoma; Human brain; Rat hippocampus; Rat brain; Human fetal brain; Mouse hippocampus; fetal hippocampus; fetal brain; MCF7 cell; SH-SY5Y cell |
|---|---|
| Controllo negativo |
| WB |
|---|
Experimental Protocol:
Sample preparation
1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail),and homogenize the tissue at a low temperature. 2. Adherent cell: Aspirate the culture medium and wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) and put the sample on ice for 5 min. 3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) and put the sample on ice for 5 min. 4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant;
5. Remove a small volume of lysate to determine the protein concentration;
6. Combine the lysate with protein loading buffer. Boil 20 µL sample under 95-100°C for 5 min. Centrifuge for 5 min after cool down on ice.
Electrophoretic separation
1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Recommended separating gel (lower gel) concentration: 10%. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations 2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
Transfer membrane
1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip"; 4. The protein was electrotransferred to PVDF membrane. ( 0.45 µm PVDF membrane is recommended ) Reference Table for Selecting PVDF Membrane Pore Size Specifications Recommended conditions for wet transfer: 200 mA, 120 min. ( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
Block
1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
2. Incubate the film in the blocking solution for 1 hour at room temperature;
3. Wash the film with TBST for 3 times, 5 minutes each time.
Antibody incubation
1. Use 5% skim milk powder to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:1000), gently shake and incubate with the film at 4°C overnight; 2. Wash the film with TBST 3 times, 5 minutes each time;
3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
Antibody staining
1. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system. |
| IHC |
|---|
Experimental Protocol:
Deparaffinization/Rehydration
1. Deparaffinize/hydrate sections:
2. Incubate sections in three washes of xylene for 5 min each.
3. Incubate sections in two washes of 100% ethanol for 10 min each.
4. Incubate sections in two washes of 95% ethanol for 10 min each.
5. Wash sections two times in dH2O for 5 min each.
6.Antigen retrieval: For Citrate: Heat slides in a microwave submersed in 1X citrate unmasking solution until boiling is initiated; continue with 10 min at a sub-boiling temperature (95°-98°C). Cool slides on bench top for 30 min.
Staining
1. Wash sections in dH2O three times for 5 min each.
2. Incubate sections in 3% hydrogen peroxide for 10 min.
3. Wash sections in dH2O two times for 5 min each.
4. Wash sections in wash buffer for 5 min.
5. Block each section with 100–400 µl of blocking solution for 1 hr at room temperature.
6. Remove blocking solution and add 100–400 µl primary antibody diluent in to each section. Incubate overnight at 4°C.
7. Remove antibody solution and wash sections with wash buffer three times for 5 min each.
8. Cover section with 1–3 drops HRPas needed. Incubate in a humidified chamber for 30 min at room temperature.
9. Wash sections three times with wash buffer for 5 min each.
10. Add DAB Chromogen Concentrate to DAB Diluent and mix well before use.
11. Apply 100–400 µl DAB to each section and monitor closely. 1–10 min generally provides an acceptable staining intensity.
12. Immerse slides in dH2O.
13. If desired, counterstain sections with hematoxylin.
14. Wash sections in dH2O two times for 5 min each.
15. Dehydrate sections: Incubate sections in 95% ethanol two times for 10 sec each; Repeat in 100% ethanol, incubating sections two times for 10 sec each; Repeat in xylene, incubating sections two times for 10 sec each.
16. Mount sections with coverslips and mounting medium.
|
| Specificità |
|---|
| TYRO3 Antibody [L10H9] detects endogenous levels of total TYRO3 protein. |
| Uniprot ID |
|---|
| Q06418 |
| Clone |
|---|
| L10H9 |
| Sinonimo |
|---|
| BYK, DTK, RSE, SKY, TIF, TYRO3, Tyrosine-protein kinase receptor TYRO3, Tyrosine-protein kinase BYK, Tyrosine-protein kinase DTK, Tyrosine-protein kinase RSE, Tyrosine-protein kinase SKY, Tyrosine-protein kinase TIF |
| Background |
|---|
| Tyrosine-protein kinase receptor TYRO3 (TYRO3) is a membrane-bound receptor tyrosine kinase (RTK) belonging to the TAM receptor family, which also includes AXL and MERTK. Members of this family share a conserved extracellular domain architecture consisting of two N-terminal immunoglobulin-like (Ig) domains followed by two fibronectin type III (FNIII)-like domains, which mediate ligand recognition and receptor dimerization. TYRO3 is expressed across multiple tissues, with particularly high abundance in the central nervous system, reproductive organs, and immune cells, highlighting its broad physiological relevance. Functionally, TYRO3 serves as a critical regulator of cell survival, proliferation, differentiation, and immune modulation. Together with AXL and MERTK, TYRO3 binds the vitamin K–dependent ligands Gas6 (growth arrest–specific 6) and Protein S, which facilitate receptor activation and downstream signal transduction. TYRO3-mediated signaling plays an essential role in the clearance of apoptotic cells (efferocytosis) and the suppression of excessive inflammatory responses, processes fundamental for maintaining immune homeostasis and tissue integrity. In the nervous system, TYRO3, along with MERTK, contributes to the phagocytic removal of photoreceptor outer segments by retinal pigment epithelial cells, while AXL supports oligodendrocyte survival. Through activation of intracellular signaling cascades such as the PI3K/AKT and MAPK/ERK pathways, TYRO3 promotes cell cycle progression, metabolic regulation, and protection against cellular stress. The integration of TYRO3 signaling with that of its TAM family counterparts enables fine-tuned coordination of immune regulation, tissue repair, and neuronal maintenance. Dysregulation of this receptor’s activity has been associated with autoimmune disorders, neurodegenerative diseases, and tumor progression, underscoring its pivotal role in sustaining cellular equilibrium and organismal homeostasis. |
| Riferimenti |
|---|
|
Istruzioni per la manipolazione
Tel: +1-832-582-8158 Ext:3
Per qualsiasi altra domanda, si prega di lasciare un messaggio.